Skip to main content

Month: March 2025

Aurora Mobile’s GPTBots.ai and ZANROO Forge Alliance to Ignite AI Innovation in Southeast Asia

SHENZHEN, China, March 20, 2025 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its leading enterprise AI agent platform, GPTBots.ai, has recently entered into a strategic partnership with ZANROO MALAYSIA SDN. BHD. (“ZANROO”), a fast-growing marketing technology company in Southeast Asia. This collaboration intends to drive the adoption and application of AI solutions in the region through joint business scenario solutions, thematic campaigns, and regional joint branding efforts. GPTBots.ai and ZANROO are excited to embark on this strategic partnership, which promises to unlock new opportunities for AI solutions in Southeast Asia. Chris Lo, Founder and CEO of...

Continue reading

Totalkredit A/S – annual general meeting 2025

To Nasdaq Copenhagen Totalkredit A/S – annual general meeting 2025 At Totalkredit’s annual general meeting held on Thursday 20 March 2025:The Annual Report 2024, including the proposal for distribution of net profit, was approved. Discharge of the Board of Directors and Executive Board was adopted. The Board of Directors’ proposals for remuneration policy, remuneration report and Management remuneration were adopted. Michael Rasmussen, David Hellemann, Anders Jensen and Pernille Sindby were re-elected to the Board of Directors. EY Godkendt Revisionspartnerselskab was reappointed as the Company’s auditors and EY Godkendt Revisionspartnerselskab was appointed as the Company’s sustainability auditors. Amendment of the Company’s Articles of Association was approved, to the effect that the Board of Directors...

Continue reading

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 28 02 2025

DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 28 FEVRIER 2025 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMFNombre d’actions composant le capital social 236 664 445Nombre de droits de vote théoriques 269 849 369Nombre de droits de vote exerçables 269 668 675Cette déclaration est en ligne sur le site internet d’Elis www.elis.com DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING RIGHTS AS OF 28 FEBRUARY 2025Total number of shares 236,664,445Theoretical number of voting rights 269,849,369Number of exercisable voting rights 269,668,675This disclosure is on Elis web site www.elis.com          Contacts Nicolas Buron, Director of Investor Relations, Financing & TreasuryPhone: +33 1 75 49 98 30 –...

Continue reading

Continued momentum for Oxford Metrics’ smart manufacturing division

20 March 2025 Oxford Metrics plc (“Oxford Metrics” or the “Group”) Continued momentum for Oxford Metrics’ smart manufacturing division Appointment of smart manufacturing managing directorIndustrial Vision Systems wins three contact lens inspection contracts since October 2024 Oxford Metrics plc (LSE: OMG), the smart sensing and software company servicing life sciences, entertainment, engineering and smart manufacturing markets, is pleased to announce the appointment of Dr Simon Gunter as managing director of our smart manufacturing division. The Group also announces that Industrial Vision Systems (“IVS”) has secured three contracts for global contact lens manufacturers with a combined value of c. £1.6 million (contained within current FY25 market expectations). Appointment of managing director, smart manufacturing Dr Simon...

Continue reading

Pacific Green Completes Sale of 250MW / 500 MWh Limestone Coast North Battery Energy Park Development

Sydney, March 20, 2025 (GLOBE NEWSWIRE) — Pacific Green Technologies, Inc. (“Pacific Green”, OTCQB: PGTK) announces that it has reached Financial Close and completed the sale of 100% of the shares in its Limestone Coast North Energy Park to Intera Renewables (Intera) in a deal representing an enterprise value of A$460 million (US$293 million) (the “Transaction”). The Limestone Coast North Energy Park is Pacific Green’s 250MW / 500MWh battery energy storage development and is one of two battery parks to be co-located on a site in the south east of South Australia. The project is the first of the company’s 10GWh Australian project pipeline to reach Financial Close. This achievement underscores Pacific Green’s commitment to delivering innovative energy solutions and contributing to a sustainable future. With the transaction...

Continue reading

Nokia launches FastMile Gateway 4, enhancing its Wi-Fi 7 enabled FWA portfolio

Nokia FastMile 5G Gateway 4 ProductNokia FastMile 5G Gateway 4 ProductNokia FastMile 5G Gateway 4 LifestyleNokia FastMile 5G Gateway 4 LifestylePress ReleaseNokia launches FastMile Gateway 4, enhancing its Wi-Fi 7 enabled FWA portfolioNew, compact 5G Fixed Wireless Access (FWA) gateway with Wi-Fi 7, designed to deliver seamless 5G speeds throughout the home for an enhanced user experience, Delivers superior performance enabling Wi-Fi speeds of up to 4Gbps for faster, more reliable connectivity. Nokia comprehensive FastMile gateway portfolio now includes more FWA options including indoor, outdoor and window mount options to meet operator needs.20 March 2025Amsterdam, Netherlands – Nokia today announced the launch of the FastMile Gateway 4, a new compact 5G indoor gateway with Wi-Fi 7 that enables operators to deliver...

Continue reading

NTG Nordic Transport Group acquires DTK

Company announcement no. 5 – 25        20 March 2025 NTG Nordic Transport Group acquires DTK NTG Nordic Transport Group A/S (“NTG”) has signed an agreement to acquire 100% of the shares in Danish-based DTK BE Holding ApS (“DTK”). DTK is a full-service, end-to-end logistics solutions provider specialising in full- and part-load general cargo and temperature-controlled road freight services. In addition, DTK offers logistics services and warehousing solutions for a range of long-standing customers. Headquartered in Padborg, DTK operates from eight different locations across Denmark (five), Germany (one), Sweden (one), and the UK (one). DTK employs approximately 115 white-collar and 80 blue-collar employees. For the financial year ending 31 December 2024, DTK realised DKK 1,156 million in net revenue and an EBIT of DKK 94 million (Danish...

Continue reading

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane Biopharma AB’s (“Xbrane”) R&D operations and a biosimilar candidate (the “Acquisition”), further expanding Alvotech’s development capabilities, and establishing a footprint in the Swedish life science sector. The Acquisition includes Xbrane’s R&D operations based in Campus Solna, at the Karolinska Institute outside Stockholm, Sweden, as well as the biosimilar candidate XB003, referencing Cimzia® (certolizumab pegol). Xbrane retains other pre-clinical assets and will focus on the commercialization of this portfolio. Alvotech also announced that it intends to explore the possibility of a listing of Swedish Depository Receipts (SDR), equity share...

Continue reading

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) —  Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane Biopharma AB’s (“Xbrane”) R&D operations and a biosimilar candidate (the “Acquisition”), further expanding Alvotech’s development capabilities, and establishing a footprint in the Swedish life science sector. The Acquisition includes Xbrane’s R&D operations based in Campus Solna, at the Karolinska Institute outside Stockholm, Sweden, as well as the biosimilar candidate XB003, referencing Cimzia® (certolizumab pegol). Xbrane retains other pre-clinical assets and will focus on the commercialization of this portfolio. Alvotech also announced that it intends to explore...

Continue reading

Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market

Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market Amsterdam, 20 March 2025 – Arcadis, a global leader in intelligence-driven sustainable design, engineering, and consultancy solutions, has announced the acquisition of WSP Infrastructure Engineering GmbH, a 160-people strong, German based engineering firm specialized in rail infrastructure, signaling, structural engineering and software development. This acquisition will double Arcadis’ presence in the German rail market, strengthening its position for growth. WSP Infrastructure Engineering GmbH is known for its strong capabilities in German rail design and engineering and holds critical pre-qualifications for framework agreements with Deutsche Bahn. These are complementary to Arcadis’ current activities in the German...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.